Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet-induced obesity and diabetes. Obese LGALS3 2/2 mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese LGALS3 2/2 mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory CD11c + CD11b
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Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet-induced obesity and diabetes. Obese LGALS3 2/2 mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese LGALS3 2/2 mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory CD11c +
CD11b
+ macrophages and decreased CD4 + CD25 + FoxP3 + regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1b (IL-1b) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese LGALS3 2/2 animals accompanied with elevated phosphorylated nuclear factor-kB (NF-kB) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of LGALS3 2/2 peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1-dependent IL-1b production and increased phosphorylation of NF-kB p65 compared with WT cells. Transfection of LGALS3 2/2 macrophages with NLRP3 small interfering RNA attenuated IL-1b production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes. Diabetes 62: [1932] [1933] [1934] [1935] [1936] [1937] [1938] [1939] [1940] [1941] [1942] [1943] [1944] 2013 M etabolic inflammation, "metaflammation," is a chronic, low-grade adipose tissue inflammation triggered by various metabolic "danger" signals during obesity that precedes the development of insulin resistance and type 2 diabetes (1). Adipose tissue-associated regulatory T cells (Tregs), type 2 T helper cells, and alternatively activated M2 macrophages protect from the instigation of nutrient excessinduced inflammation (2) , whereas the recruitment of type 1 T helper lymphocytes and M1 macrophages and decreased Tregs in adipose tissue precede metabolic disorders (3, 4) . Proinflammatory interleukin-1b (IL-1b) and tumor necrosis factor-a impair insulin sensitivity, but molecular pathways that associate inflammation, diet, and type 2 diabetes are not fully understood (5) . It has been postulated that the activation of nuclear factor-kB (NF-kB), a family of transcription factors that regulate the expression of proinflammatory genes upon cell stimulation with various factors including hyperglycemia and free fatty acids, is a molecular mechanism involved in insulin resistance (6) . Most recently, the crucial role for the NLRP3 inflammasome, which consists of NLRP3 molecules, adaptor protein ASC, and procaspase-1 that catalytically activates caspase-1, causing the release of IL-1b and IL-18, was demonstrated in studies in which the ablation of the NLRP3 inflammasome prevented obesityinduced inflammation and insulin resistance (7) (8) (9) .
Galectin-3 (Gal-3; also known as Mac-2), a 30-kDa b-galactoside-binding lectin, mainly located in the cytoplasm, but also in the nucleus, is expressed by a variety of cell types and regulates various T-cell functions and innate immune responses (10) . Gal-3 plays an important diseaseexacerbating role in autoimmune/inflammatory and malignant diseases (11) (12) (13) (14) . Gal-3 is also one of the pattern recognition receptors that bind and mediate the degradation of modified lipoproteins and advanced glycation end products (AGEs) (15) . In contrast to other receptors for AGE (RAGEs), Gal-3 acts to protect from AGE-induced tissue injury. Therefore, Gal-3 ablation accelerates AGEinduced kidney injury in diabetes (16) and enhances atherogenesis (17) . Gal-3 protects b-cells from the cytotoxic effect of IL-1b in rats (18) and its increased expression was demonstrated in islet endothelial cells in obesity-induced diabetes in mice (19) .
The aim of this study was to investigate the role of Gal-3 in high-fat diet (HFD)-induced obesity and associated metabolic abnormalities by using mice lacking Gal-3 on a C57BL/6 background. We report here that Gal-3 ablation accelerated HFD-induced obesity and amplified inflammation in adipose tissue and pancreatic islets.
RESEARCH DESIGN AND METHODS
Experimental mice. Male Gal-3-deficient (LGALS3 2/2 ) mice on the C57BL/6 background and their littermate controls, wild-type (WT) C57BL/6 mice (6 weeks of age), obtained from the University of California Davis (Davis, CA; by courtesy of D.K. Hsu and F.T. Liu) were fed either a low-fat diet (LFD; 3% fat) or HFD (60% fat) obtained from Mucedola (Milano, Italy) for 11 or 18 weeks. All animal procedures were approved by the ethical committee (04/11) of the Faculty of Medical Sciences, University of Kragujevac. Metabolic parameters. Body weights and fasting blood glucose levels were measured once every 2 weeks. Mice were fasted for 4 h, and glucose levels (mmol/L) were determined using the Accu-Chek Performa glucometer (Roche PD-1 + cells in VAT and spleen from HFD-fed LGALS3 2/2 mice vs. WT mice on both diet conditions. The results are shown as the means 6 SEM for four to six animals per group. FSC-H, forward-scattered light; FITC, fluorescein isothiocyanate; SSC-H, side-scattered light in flow cytometry; SVF, stromal vascular fraction. *P < 0.05.
sections were mounted with ProLong Gold antifade reagent with DAPI (Invitrogen) and analyzed at 340 magnification using the Nikon Eclipse Ti-E inverted research microscope equipped with NIS-Elements Imaging software (Nikon Instruments Inc., Melville, NY). Only brightness and contrast were adjusted. Immunohistochemistry. Pancreatic tissue cryosections were incubated with biotinylated F4/80 antibody (Invitrogen) followed by visualization using the Mouse-Specific HRP/DAB Detection IHC Kit (Abcam). Next, they were incubated with rabbit anti-mouse NLRP3, IL-1b, AGE, RAGE, and Gal-3, visualized by rabbit-specific conjugate (Expose Rb-Specific HRP/AEC Detection IHC Kit; Abcam), photomicrographed with a digital camera mounted on light microscope (Olympus BX51), digitized, and analyzed (24) . Results are expressed as percent positive staining in the specified region. Cell culture. Macrophages were collected from the peritoneal cavity of mice under sterile conditions and cultured in complete Dulbecco's modified Eagle's medium supplemented with 10% FCS at 37°C in a 5% CO 2 incubator. After pretreatment with lipopolysaccharide (LPS) (100 ng/mL) for 4 h, cells were stimulated with BSA alone or palmitate-BSA (100 mmol/L), glucose (22 mmol/L), and H 2 O 2 (10 mmol/L) (all from Sigma-Aldrich) for 24 h. Where indicated, cells were preincubated with the caspase-1 inhibitor Z-YVAD-FMK (10 mmol/L; Bachem AG, Bubendorf, Switzerland). Caspase-1 activity assay. For the determination of caspase-1 activity, we used the Caspase-1 Colorimetric Kit (R&D Systems) according to the manufacturer's recommendations. NLRP3 knockdown with small interfering RNA transfection. Peritoneal macrophages were seeded on six-well plates (1 3 10 6 cells/well), washed once with 2 mL small interfering RNA (siRNA) transfection medium, transfected with 60 pmol NLRP3 siRNA or 60 pmol negative control siRNA, and incubated for 7 h according to the manufacturer's instructions (Santa Cruz Biotechnology, Santa Cruz, CA). Western blot. Pancreatic tissue lysates were prepared in a solution containing 62.5 mmol/L Tris-HCl, pH 6.8, 2% weight/volume (wt/vol) SDS, 10% glycerol, 50 mmol/L dithiothreitol, 0.01% wt/vol bromophenol blue, 1 mmol/L phenylmethylsulphonyl fluoride, 1 mg/mL aprotonin, and 2 mmol/L EDTA, and proteins from VAT were isolated with TRIzol reagent (Genosys, Woodlands, TX) and further processed (25) . Rabbit polyclonal IgG antibodies to ASC (1:500), NLRP3 (1:500), IL-1b (1:2500), caspase-1 (1:500), NF-kB p65 (phospho-S536) (1:500), and NF-kB p65 (1:500) (all from Abcam) and mouse anti-mouse IgG1 b-actin antibody (1:500) (Sigma-Aldrich) as internal control were used, followed by donkey anti-rabbit horseradish peroxidase at 1:10,000 or sheep antimouse horseradish peroxidase (1:2,500) (GE Healthcare, Buckinghamshire, U.K.). Detection was performed by chemiluminescence (ECL; GE Healthcare), and photographs were made by X-ray films (Kodak). Scion Image Alpha 4.0.3.2 (Scion Corporation, Frederick, MD) was used to calculate protein expression. Cytokine measurement. Cytokine levels were determined using mouse duo sets for IL-1b/IL-1F2, IL-6, IL-4, IL-13, IL-10, IFN-g, IL-17, and CRP (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's recommendations. Statistical analyses. All data are presented as means 6 SEM. Statistical significance was determined by ANOVA (one-way ANOVA and Bonferroni post hoc test), independent-sample Student t test, and, where appropriate, KruskalWallis and Mann-Whitney U test. Relationships between variables were assessed using Pearson correlation. Statistical significance was assumed at P , 0.05. Statistical analyses were performed using SPSS 13.0.
RESULTS
Lack of Gal-3 accelerates HFD-induced obesity and obesity-related metabolic abnormalities. Body weight (Fig. 1A) and total VAT weight (Fig. 1B) + macrophages with body weights (r = 0.919, P = 0.001) and fasting blood glucose levels (r = 0.912, P = 0.002) in LGALS3 2/2 mice. D: Inverse correlation between the frequencies of Tregs with body weights (r = 0.633, P = 0.067) and blood glucose levels (r = 0.819, P = 0.007) in LGALS3 2/2 mice. r, Pearson correlation coefficient. The results are shown as the means 6 SEM for four to six animals per group. SVF, stromal vascular fraction. *P < 0.05; §P < 0.05. (Fig. 1A and B) . There was no difference in food intake between LGALS3 2/2 and WT mice (Fig. 1A) . Fasting blood glucose levels and insulinemia and HbA 1c were significantly increased in HFD-fed LGALS3 2/2 mice compared with other experimental groups at both 11 and 18 weeks, whereas in WT mice on HFD versus LFD at 18 weeks, the differences did not reach statistical significance (Fig. 1C  and D) . Hyperglycemia was noticed in LGALS3 2/2 mice fed LFD at 18 weeks (Fig. 1C) . Of note, the significantly increased body weight (26.25 6 0.66 vs. 22.19 6 0.67 g, P = 0.010) and fasting glycemia (8.92 6 0.47 vs. 6.82 6 0.31 mmol/L, P = 0.004) were already noticed after 3 weeks of HFD in LGALS3 2/2 mice compared with diet-matched WT mice. HbA 1c (%) and fasting glycemia significantly correlated in LGALS3 2/2 mice at 18 weeks (Fig. 1C) . HOMA-IR was significantly higher in HFD-fed LGALS3 2/2 mice compared with other experimental groups at 11 and 18 weeks (Fig. 1E) . Total, HDL, and non-HDL cholesterol serum levels increased with HFD but were not significantly different between the genotypes, and serum levels of triglycerides were similar between experimental groups at 11 weeks (data not shown + FoxP3 + Tregs were significantly lower in the VAT and spleens (P = 0.071) of obese LGALS3 2/2 mice compared with other experimental groups (Fig. 2C and D + adipose tissue macrophages significantly correlated with body weight (r = 0.919, P = 0.001) and fasting blood glucose levels (r = 0.912, P = 0.002) (Fig. 3C) , whereas Tregs inversely correlated with body weight (r = 0.633, P = 0.067) and fasting glycemia (r = 0.819, P = 0.007) (Fig. 3D ) in contrast to WT mice (data not shown). Systemic inflammatory profile in obese LGALS3 2/2 mice fed HFD for 11 weeks. Original magnification 340. Scale bars, 100 mm. B: Pancreatic islet inflammation (insulitis) was graded from 1 to 5, according to the extent of peri-and intraislet infiltration by mononuclear leukocytes as follows: 1, no islet infiltration; 2, peri-vascular/periductal islet infiltration; 3, peri-insulitis; 4, mild insulitis (<25% islet area infiltrated); 5, severe insulitis (>25% islet area infiltrated).
LGALS3 2/2 mice on HFD had a significantly increased percentage of islets with severe insulitis compared with other experimental groups.
LGALS3 2/2 mice on LFD had a significantly higher percentage of severe insulitis compared with WT mice on both diet conditions. The results are shown as percentages of islets with insulitis derived from four to six mice per group. **P < 0.001; ¶P < 0.05; §P < 0. 
LACK OF GAL-3 ACCELERATES OBESITY AND DIABETES
the systemic inflammatory profile in studied mice. CRP, IL-6, and IL-4 levels significantly increased in the sera of LGALS3 2/2 mice with HFD, whereas IL-13 and IL-10 levels significantly decreased compared with diet-matched WT mice at 11 weeks (Fig. 4A) . After 18 weeks on HFD, IL-4 and IL-1b levels were significantly higher, whereas IL-10 levels remained significantly lower in LGALS3 2/2 mice (Fig. 4B) , with no significant difference in the serum levels of IFN-g (Fig. 4A and B) and IL-17 (data not shown) compared with WT mice. Pronounced mononuclear cell infiltration in pancreatic islets in obese LGALS3 2/2 mice. Given the fact that LGALS3 2/2 mice exhibited obesity-related abnormalities of glucose metabolism, we performed histological analysis of the distribution of inflammatory cell infiltrate in pancreatic islets from LGALS3 2/2 and WT mice fed HFD or LFD for 11 weeks (Fig. 5A) . We found significantly increased average insulitis as expressed by the insulitis score in HFD-fed LGALS3 2/2 mice compared with other experimental groups (Fig. 5B) . The percentage of total intact islets and those with perivascular/periductal and peri-insulitis was 58% in LGALS3 2/2 mice compared with 89% in WT mice, both on HFD (P , 0.001). The percentages of islets with mild or severe insulitis were 24 and 17%, respectively, in HFD-fed LGALS3 2/2 mice compared with 10% of islets with mild insulitis and none with severe insulitis in WT mice fed HFD (both P , 0.001). Of note, the percentages of islets with mild or severe insulitis were 17 and 5% in LFD-fed LGALS3 2/2 mice compared with 2% of islets with mild insulitis (P , 0.05) and none with severe insulitis in WT mice fed LFD (P , 0.05). The percentage of islets with mild insulitis was significantly higher in HFDfed WT mice compared with LFD-fed WT mice (P , 0.05).
Flow cytometric analysis of mononuclear cells isolated from digested pancreata of obese LGALS3 2/2 mice revealed that the majority of cells were F4/80 + CD11b + myeloid cells, among which the proinflammatory F4/ 80 + CD11c + CD11b + BMDCs were the predominant cell type (Fig. 5C ). Higher incidence of NLRP3 inflammasome and IL-1b-expressing macrophages in islets and adipose tissue in obese LGALS3 2/2 mice. We next sought to assess NLRP3 inflammasome and IL-1b expression in pancreatic islets of mice fed HFD for 11 weeks. Immunofluorescence and morphometric immunohistochemical data showed increased NLRP3 inflammasome expression in islets of HFDfed LGALS3 2/2 mice (Fig. 6A , top) compared with HFD-fed WT mice (Fig. 6A, bottom) with a significantly higher percentage of NLRP3 inflammasome-positive area in islets of obese LGALS3 2/2 mice (Fig. 6B ) and prominent infiltration of F4/80 + macrophages (Fig. 6C) . Also, increased IL-1b expression in islets from obese LGALS3 2/2 mice (Fig. 6D, top) compared with HFD-fed WT mice (Fig. 6D , bottom) was found with a significantly higher percentage of IL-1b-positive area in islets of obese LGALS3 2/2 mice ( Fig. 6E and F) . IL-18 was not detected (data not shown). Furthermore, we show significantly higher percentages of NLRP3 inflammasome-and IL-1b-expressing macrophages derived from digested pancreatic tissue (Fig. 6G) and VAT (Fig. 6H ) from HFD-fed LGALS3 2/2 mice compared with diet-matched WT controls.
Western blot analyses showed a similar expression of NLRP3 inflammasome in pancreata among experimental groups and significantly increased expression of ASC in HFD-fed LGALS3 2/2 mice compared with LFD-fed LGALS3 2/2 and WT mice (both P , 0.05). Procaspase-1 was significantly increased in HFD-fed LGALS3 2/2 mice compared with other experimental groups (all P , 0.05) and mature caspase-1 in comparison with LFD-fed LGALS3 2/2 mice (P , 0.05). ASC expression was significantly higher in HFD-fed WT mice compared with LFD-fed LGALS3 2/2 mice (P , 0.05) (Fig. 6I) .
In VAT, a significant increase of NLRP3 inflammasome expression was found in HFD-fed LGALS3 2/2 mice compared with LFD-fed LGALS3 2/2 and WT mice (both P , 0.05) and increased ASC and procaspase-1 in comparison with LFD-fed LGALS3 2/2 mice (both P , 0.05). Mature caspase-1 protein expression was significantly higher in obese LGALS3
2/2 mice compared with other experimental groups (all P , 0.05). NLRP3 and ASC expression were significantly lower in LFD-fed LGALS3 2/2 mice compared with HFD or LFD-fed WT mice (all P , 0.05). Procaspase-1 was significantly lower in LFD-fed LGALS3 2/2 mice compared with HFD-fed WT mice (P , 0.05) (Fig. 6J ) . Obese LGALS3 2/2 mice have higher AGE accumulation and RAGE expression in pancreatic islets. As Gal-3 has a role in the uptake and removal of metabolic compounds with proinflammatory properties related to diabetes complications, we examined the expression of AGE and RAGE in pancreatic islets. Immunofluorescence and immunohistochemical (IHC) data showed increased accumulation of AGE ( Fig. 7A and B) and an increased percentage of RAGE-positive area in islets in LGALS3 2/2 mice fed HFD for 11 weeks compared with diet-matched WT mice ( Fig. 7C and D) .
We show increased expression of Gal-3 protein in the pancreatic islets of HFD-fed WT mice compared with LFDfed WT mice at 11 weeks (Fig. 7E) . NLRP3 inflammasome expression and caspase-1-dependent IL-1b production are increased in stimulated peritoneal macrophages in LGALS3 2/2 compared with WT mice. We demonstrate the inherent genotype differences in the cellular response of LGALS3 2/2 mice vs. WT mice as LPS (100 ng/mL), palmitate-BSA (100 mmol/L), and LPS plus palmitate induced significantly higher IL-1b and IL-6 production in LGALS3 2/2 peritoneal macrophages (Fig. 8A ). IL-1b production was significantly reduced in the presence of the caspase-1 inhibitor Z-YVAD-FMK (10 mmol/L), whereas group). *P < 0.05. and WT mice, significantly higher procaspase-1 expression when compared with all experimental groups, and significantly higher active caspase-1 expression when compared with LGALS3 2/2 mice fed LFD (all *P < 0.05). ASC expression was significantly higher in HFD-fed WT mice compared with LFD-fed LGALS3 2/2 mice. ¶P < 0.05. J: Western blot analyses of NLRP3, ASC, procaspase-1, and caspase-1 expression in VAT.
LGALS3
mice on HFD showed significantly increased expression of NLRP3 when compared with LFD-fed LGALS3 2/2 and WT mice and significantly increased expression of active caspase-1 when compared with all experimental groups (all *P < 0.05). NLRP3 and ASC expression were significantly lower in LFD-fed LGALS3 2/2 mice compared with HFD or LFD-fed WT mice (all ¶P < 0.05). Procaspase-1 was significantly lower in LFD-fed LGALS3 2/2 mice compared with HFD-fed WT mice. ¶P < 0.05. The results are representative of two to three repeated experiments.
IL-6 production was not affected (Fig. 8A) . No significant difference in IL-1b production between LGALS3 2/2 and WT mice was observed when cells were stimulated with high glucose or H 2 O 2 with and without priming with LPS (data not shown).
In vitro stimulation of cells with LPS or palmitate significantly increased percentages of NLRP3 inflammasomeexpressing F4/80 + macrophages (Fig. 8B) and significantly increased caspase-1 activity (Fig. 8C) in LGALS3 2/2 compared with WT macrophages. Transfection of LGALS3 2/2 peritoneal macrophages with NLRP3 siRNA resulted in a significant reduction of the NLRP3 inflammasome expression compared with cells transfected with control siRNA (15.6 vs. 3.7%) (Fig. 8D) . Transfection with NLRP3 siRNA, but not with control siRNA, led to a significant decrease in IL-1b production by LGALS3 2/2 macrophages stimulated with palmitate alone and LPS plus palmitate (Fig. 8D) . Increased activation of NF-kB in LGALS3 2/2 mice. We next tested for the differences in NF-kB activation in LGALS3 2/2 vs. WT mice by using an antibody against the NF-kB p65 subunit phosphorylated at the amino acid residue serine 536, an activated form of NF-kB that is induced in response to a variety of proinflammatory stimuli, including LPS. Figure 8E represents the percentage of phospho-NF-kB p65-expressing peritoneal macrophages in response to LPS (1 mg/mL) with and without palmitate (100 mmol/L). A significant increase of phospho-NF-kB p65-expressing F4/80 + macrophages in LGALS3 2/2 compared with WT cells in response to LPS and LPS plus palmitate was observed (Fig. 8E) . 
FIG. 8. Stimulated
LGALS3 2/2 peritoneal macrophages have increased NLRP3 inflammasome expression, caspase-1-dependent IL-1b production, and higher expression of phosphorylated NF-kB p65. A: Significantly higher production of IL-1b by LGALS3 2/2 vs. WT peritoneal macrophages upon simulation with LPS (100 ng), palmitate-BSA (PA-BSA) (100 mmol/L), or LPS plus PA, whereas the production was significantly reduced in the presence of the caspase-1 inhibitor Z-YVAD (10 mmol/L).
LGALS3 2/2 macrophages stimulated with LPS, PA, or LPS plus PA produce more IL-6 when compared with WT macrophages, and the production was not affected by caspase-1 inhibitor Z-YVAD. Western blotting showed significantly increased expression of phospho-NF-kB p65 in pancreata of LGALS3 2/2 fed HFD for 18 weeks compared with other experimental groups (all P , 0.05) (Fig. 8F) . Phospho/total ratio of NF-kB p65 was the highest in the pancreata of HFD-fed LGALS3 2/2 mice (0.816) compared with HFD-fed WT mice (0.413) and LFD-fed LGALS3 2/2 mice (0.120) or WT animals (0.345). In VAT, phospho-NF-kB p65 expression was significantly higher in HFD-fed LGALS3 2/2 mice compared with LFD-fed LGALS3 2/2 mice (P , 0.05) (Fig. 8F) . Phospho/total ratio of NF-kB p65 was the highest in the VAT of HFD-fed LGALS3 2/2 mice (0.842) compared with HFD-fed WT mice (0.469) and LFD-fed LGALS3 2/2 mice (0.370) or WT animals (0.272).
DISCUSSION
This study provides evidence that knockdown of Gal-3 results in accelerated HFD-induced obesity and diabetes, as indicated by the significantly higher body weight and total VAT weight, hyperglycemia, increased HOMA-IR, severe insulitis, and pronounced infiltration of pancreatic islets with proinflammatory macrophages. Ongoing inflammation in largely expanded adipose tissue in obese LGALS3 2/2 mice was characterized by the increased incidence of type 1 CD3 + T and CD3 + NK1.1 + NKT lymphocytes expressing IFN-g. Th1 effector cells have a major role in obesity-associated chronic inflammation (26) , and NKT cell depletion prevents diet-induced metaflammation and glucose intolerance (27) (31) . Markedly reduced alternatively activated M2 macrophages in the VAT of LGALS3 2/2 mice are in line with the reported data of Gal-3 involvement in the polarization of M2 macrophages (32, 33) .
Accelerated HFD-induced obesity in Gal-3-deficient mice was associated with systemic inflammation. Increased IL-6 and IL-1b induced by HFD in LGALS3 2/2 mice are in line with the data of increased production of IL-1b and IL-6 in Gal-3-deficient macrophages during infection (34) . Increased systemic IL-4 might indicate enhanced T-cell function during nutrient excess in LGALS3 2/2 mice as Gal-3-deficient CD4 + T cells were shown to produce increased amounts of IFN-g and IL-4 after T-cell receptor engagement (35) . Lack of Gal-3 on dendritic cells favors lower IL-10 production and increased IFN-g by allogeneic T cells (36) . Reduced levels of IL-13 and IL-10 in the sera of obese LGALS3 2/2 mice might contribute to amplified obesity-induced inflammation. IL-10 has a protective role in type 2 diabetes by increasing insulin sensitivity in skeletal muscle (37) .
The most striking finding in our study was the presence of severe insulitis in obese LGALS3 2/2 mice, but also in lean LGALS3 2/2 mice. Enhanced expression of Gal-3 protects rat pancreatic b-cells from the cytotoxic effect of IL-1b (18) , and Gal-3 is highly expressed in islet endothelial cells in obesity-induced diabetes in mice (19) 2/2 mice. Apart from macrophages, b-cells could produce IL-1b when exposed to proinflammatory metabolic signals, possibly through NLRP3 inflammasome activation (38) . Most recently, type 2 diabetes has been considered an autoinflammatory disease with the central role for NLRP3-ASC inflammasome-mediated IL-1b production (39, 40) . We did not find a significant increase in protein content of NLRP3 inflammasome in whole-tissue lysates of pancreas and VAT in HFD-fed LGALS3 2/2 mice compared with HFD-fed WT mice. However, a trend toward increased ASC and NLRP3 inflammasome protein content was found in pancreas and VAT, respectively. The increased mature caspase-1 protein expression found in the VAT of obese LGALS3 2/2 mice might indicate increased NLRP3 inflammasome activation in adipose tissue in Gal-3 deficiency. In fact, LGALS3 2/2 macrophages produced increased amounts of IL-1b, which was caspase-1 dependent, and had increased NLRP3 inflammasome expression and higher caspase-1 activity in response to LPS and/or palmitate compared with WT cells. In addition, silencing of NLRP3 by siRNA attenuated IL-1b production by LGALS3 2/2 macrophages, suggestive of the enhanced NLRP3 inflammasome activation in Gal-3-deficient mice. The most recent study shows that NLRP3 expression is increased by TLR agonists, including LPS, in murine macrophages in an NF-kB-dependent manner (41) . Moreover, LGALS3 2/2 macrophages produced increased amounts of IL-1b and IL-6 in response to LPS stimulation, which is line with the evidence of markedly elevated LPSinduced proinflammatory cytokines in Gal-3-deficient macrophages since Gal-3 binds LPS and prevents its activity (42) . HFD strongly increases intestinal permeability and increases blood levels of endotoxin (43) . Endotoxin, free fatty acids, and AGE, through TLRs and RAGE, activate NF-kB and lead to IL-1b and tumor necrosis factor-a production, thus promoting insulin resistance (39, 44) .
LGALS3 2/2 macrophages had increased expression of peritoneal macrophages stimulated with LPS (100 ng), PA (100 mmol/L), or LPS plus PA in comparison with WT peritoneal macrophages. D: Significantly reduced palmitate (100 mmol/L) and LPS (100 ng) plus palmitate (100 mmol/L) stimulated IL-1b production from LGALS3 2/2 macrophages transfected with NLRP3 siRNA compared with cells treated with control siRNA. Representative histogram of NLRP3 expression in macrophages transfected with NLRP3 siRNA or control siRNA. E: Significantly increased expression of phosphorylated NF-kB p65 in LGALS3 2/2 macrophages stimulated with LPS (1 mg/mL) and LPS plus PA (100 mmol/L) when compared with WT macrophages. Representative histograms of F4/80 + macrophages expressing NF-kB p65 (phospho-S536) in LGALS3 2/2 and WT mice. F: Western blot analyses of NF-kB p65 and phospho-NF-kB p65 expression in the pancreas and VAT. HFD-fed LGALS3 2/2 mice have significantly increased expression of phosphorylated NF-kB p65 when compared with all experimental groups in the pancreas and compared with LFD-fed LGALS 2/2 and WT mice in VAT. All experimental groups have a similar expression of total NF-kB p65 in the pancreas and VAT. The results are representative of two to three repeated experiments. *P < 0.05.
phospho-NF-kB p65 in response to LPS, which complements the reported data (45) . Increased pancreatic and also VAT phospho-NF-kB p65 expression could be related to increased accumulation of AGE and upregulation of RAGE in islets of LGALS3 2/2 mice fed HFD. These findings indicate that additional NF-kB-mediated proinflammatory pathways (46) might operate in amplified obesity-induced inflammation in LGALS3 2/2 mice. Collectively, the amplified obesity-induced inflammation in adipose tissue and pancreatic islets in LGALS3 2/2 mice suggest a protective role for Gal-3 in obesity and type 2 diabetes, which could be of therapeutic relevance.
